Reviva Pharmaceuticals Holdings Inc. (RVPH) — Cash Flow-to-Debt Ratio
Reviva Pharmaceuticals Holdings Inc. (RVPH) has a Cash Flow-to-Debt Ratio of -3.38x as of December 2025, meaning its operating cash flow of $-24.59 Trillion could theoretically repay -3% of its total liabilities ($7.28 Trillion) in one year. See Reviva Pharmaceuticals Holdings Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Reviva Pharmaceuticals Holdings Inc. Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Reviva Pharmaceuticals Holdings Inc. across 8 annual periods. Also explore RVPH shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Reviva Pharmaceuticals Holdings Inc. (2018–2025)
Year-by-year debt coverage analysis for Reviva Pharmaceuticals Holdings Inc.. For market capitalisation and broader financial context, see market value of Reviva Pharmaceuticals Holdings Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.38x | $-24.59 Trillion | $7.28 Trillion | ▼ -48.0% |
| 2024 | -2.28x | $-33.54 Million | $14.69 Million | ▼ -45.0% |
| 2023 | -1.58x | $-28.32 Million | $17.98 Million | ▲ +12.5% |
| 2022 | -1.80x | $-18.96 Million | $10.53 Million | ▲ +54.1% |
| 2021 | -3.93x | $-10.67 Million | $2.72 Million | ▼ -218.2% |
| 2020 | -1.23x | $-4.07 Million | $3.30 Million | ▼ -3748.1% |
| 2019 | -0.03x | $-218.44K | $6.81 Million | ▲ +81.8% |
| 2018 | -0.18x | $-1.07 Million | $6.09 Million | — |